This report records only the effect of gammaglobulin on maternal infection, and it is possible that the administration of gammaglobulin, though not preventing maternal rubella, may still reduce the frequency and the severity of foetal abnormalities. It is hoped to study the outcome of the pregnancies in the susceptible patients.
Summary
In six areas of England and Wales the incidence of rubellaneutralizing antibody among pregnant women exposed was found to vary from 80 to 95%.
Two different dose schedules were used and the prophylactic effect of gammaglobulin in pregnant rubella contacts was investigated. The attack rate in home contacts given 750 mg. of gammaglobulin was 26.7%. In similar contacts given an initial dose of 750 mg. followed by a further 1,500 mg. within 12 days of exposure the attack rate was 31%. In non-family contacts only one out of 69 susceptibles developed evidence of rubella infection.
It is a pleasure to record the co-operation of the many general practitioners in the areas served by the six public health laboratories; After the reports of Usher (1959 Usher ( , 1961 , who suggested that the use of glucose/sodium bicarbonate solutions had led to a significant reduction in the mortality from the respiratory distress syndrome, his form of treatment was given a preliminary trial in the neonatal ward at the Queen Elizabeth Hospital for Children during 1961 and 1962. Among 61 infants treated within 24 hours of birth with intravenous therapy according to his suggested dosage there were 18 deaths, a mortality of 29.5 %. Usher emphasized the need to start the infusion early, preferably within three hours, if it was to have any demonstrable effect on the survival rate. Our experience confirmed this, for among 10 babies whose treatment was delayed for ovet 24 hours there were nine deaths. If these babies had been included in our preliminary trial there would have been 27 deaths out of a total of 71 babies and the mortality increased to 38 %. It would, however, give a fairer estimate of the mortality if the 10 cases in which treatment had been delayed for 24 hours or more were excluded. However, even the figure of 38% is significantly lower than the average 60% mortality in .most previously reported series where bicarbonate had not been administered.
Unfortunately, in this hospital there were not enough controls to provide statistical proof that the treatment was of value, though there had been 32 babies who had received oxygen and increased humidity but no bicarbonate, and among these there were 17 deaths, a mortality of 53 %. The results are given in Table I , alongside some results reported from Glasgow (Hutchison et al., 1962) . 
Material and Method
Babies were referred from maternity units in affiliated hospitals, mostly within a few hours of delivery, on developing clinical signs of respiratory distress (R.D.S.). They were transported in portable incubators in oxygen (about 25 % concentration at the nostril) without increased humidity and before any treatment was initiated. If on arrival they were thought to conform clinically to hyaline membrane disease (H.M.D.) they were allocated alternately to one of two ways of glucose/sodium bicarbonate administration, the one parenterally through a scalp-vein needle (I.V.), the other by gavage (I.G.). Otherwise management was identical for both groups, by the same staff.
The babies were nursed in humidified incubators, and oxygen was administered in a concentration which was thought by the ward sister to be sufficient to control their cyanosis. The usual percentage ranged between 40 and 60 % at the nostril. The dosage of sodium bicarbonate in 10 % dextrose solution (65 ml./ kg./day) was regulated according to serial pH estimations of heel capillary blood (Usher, 1961 Table I ). Finally, it was necessary to exclude all those babies for whom the treatment had subsequently been changed for one reason or another. Of the remaining 79 cases 36 were in the " intragastric group" and 43 in the "intravenous group," with 8 and 17 deaths respectively (Table III) . Of the 20 cases which finally came to necropsy 18 showed typical hyaline membranes, a reflection of the accuracy of the initial diagnosis. 64-9 (22-115) Difference between mortality rates = 17-3%. S.E. of difference = 10 5: 2 (S.E.) 21. On x2 analysis, P = 0-10.
It was hoped that by alternate allocation the two groups would match. However, it will be seen that, though the mean values in many instances are comparable (Table IV) , the distribution of some important criteria is not (see Chart). Even allowing for this the difference between the mortality rates is not statistically significant (P=0.10). harmful, but less so when the intragastric route is used, because of poor absorption from the alimentary tract; and hence the lower mortality in this group. Neither of these explanations is really acceptable. It is reasonable to expect that careful correction of a metabolic acidosis will benefit a sick infant as it does when acidosis results from other causes such as severe gastroenteritis.
The published results of several trials have all shown an appreciable reduction in the mortality from the respiratory distress syndrome when intravenous infusions of glucose/ sodium bicarbonate have been administered (Usher, 1959 (Usher, , 1961 (Usher, , 1963 Hutchison et al., 1962) , and the preliminary trial of intravenous therapy in this hospital showed a definite improvement over other forms of therapy which had been used previously. Thus there is no good evidence that these infusions are harmful. The evidence of positive benefit is not quite so convincing, because it is to be expected that intensive care in special units will by itself result in an improved survival rate, but many people have been convinced of this by Usher's (1963) controlled trial.
If it is assumed that the infusion of glucose/sodium bicarbonate solutions is beneficial the results of the present trial show that it is just as effective when given by the intragastric route. In all the cases given intragastric therapy there was biochemical evidence that the bicarbonate was well absorbed and was able to correct the pH just as effectively as the intravenous bicarbonate (Table V) . Though the mortality in the intravenous group is much greater than in the intragastric group, statistical analysis shows that this difference could have occurred by chance. However, it is remarkable that the intragastric group seems to fare better in consideration of nearly all criteria, and it may be that the greater degree of handling necessary for intravenous therapy is an important factor.
Absorption from the neonatal gut is facilitated by the presence of a well-developed mucosa, though its rate in the first few hours is uncertain. There has been evidence of good absorption of sodium bicarbonate from the gut of babies in this trial, not only from the satisfactory correction of an existing meta- In each case, column 1 represents initial findings. Column 2 represents the finding after less than 24 hours' sodium bicarbonate therapy. bolic acidosis, but also from the considerable rise in the total bicarbonate in several cases.
Administration of these infusions by the gastric route has obvious merits, and now that it has been shown that the results are as good as those obtained by intravenous therapy, if not better, it can be firmly recommended as the route of first choice. Rarely, resort has to be made to the intravenous route because of vomiting.
Summary
A clinical trial was carried out to compare the relative values of the intravenous and the intragastric routes for infusion of solutions of glucose and sodium bicarbonate in the management of babies with the respiratory distress syndrome. Somewhat surprisingly those babies who received their infusions intragastrically had a lower mortality rate. Though the difference between the mortality rates was not statistically significant, there is reason to believe that the intragastric route of administration should be preferred.
